Form 8-K - Current report:
SEC Accession No. 0000950170-25-039826
Filing Date
2025-03-17
Accepted
2025-03-17 07:05:09
Documents
13
Period of Report
2025-03-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K catx-20250317.htm   iXBRL 8-K 44371
2 EX-99.1 catx-ex99_1.htm EX-99.1 37903
3 GRAPHIC img236230851_0.jpg GRAPHIC 19145
  Complete submission text file 0000950170-25-039826.txt   233410

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT catx-20250317.xsd EX-101.SCH 25913
15 EXTRACTED XBRL INSTANCE DOCUMENT catx-20250317_htm.xml XML 4918
Mailing Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121
Business Address 2401 ELLIOTT AVENUE SUITE 320 SEATTLE WA 98121 206-676-0900
Perspective Therapeutics, Inc. (Filer) CIK: 0000728387 (see all company filings)

EIN.: 411458152 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33407 | Film No.: 25742326
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)